Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Jim Van Meerten

This ‘Strong Buy’ Stock Is Trading at New 20-Year Highs

  • Insmed (INSM) is a biopharmaceutical company with strong momentum.
  • Shares are trading at new 20-year highs.
  • INSM has surged 128% over the past year.
  • Analysts expect robust revenue and earnings growth, but opinions are mixed, with some cautioning the stock is overvalued. 

Today’s Featured Stock

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.